Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.074 | 0.6 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |